CGI Pharmaceuticals
acquired
acquired
Stage
About
CGI Pharmaceuticals was a development-stage biotechnology company founded in 2001 that discovered and developed small-molecule kinase inhibitors targeting oncology, angiogenesis, and autoimmune, allergic and inflammatory diseases. The company was acquired by Gilead Sciences in 2010 for $120M.
Explore CGI Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.